| Uniprot ID: | |
| Secondary ID: | |
| Symbol: | miR-34 |
| Other Name: | |
| Class: | Epigenetics |
| Type: | pro/anti-fibrotic |
| Molecular Function: |
| Category I | Category II | Category III |
|---|---|---|
| Intracellular | Epigenetics | microRNA |
Reference Record 1
| PubMed ID | 28796252 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Airway fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Nur77-mediated autophagy | ||
Reference Record 2
| PubMed ID | 28273432 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting p53-miR-34a | ||
Reference Record 3
| PubMed ID | 27979858 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | |||
| Process II | cells apoptosis | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Sirt1,E2F3 and cyclin E2 | ||
Reference Record 4
| PubMed ID | 27977785 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Retinal fibrosis |
| Process I | |||
| Process II | cells proliferation | ||
| Process III | |||
| Mechanism | Targeting LGR4 | ||
Reference Record 5
| PubMed ID | 26437572 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs activation | ||
| Process III | |||
| Mechanism | Targeting ACSL1 | ||
Reference Record 6
| PubMed ID | 25370690 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs activation | ||
| Process III | |||
| Mechanism | Targeting PPARγ | ||
Reference Record 7
| PubMed ID | 24986745 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 8
| PubMed ID | 22363487 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | EMT | ||
| Process III | |||
| Mechanism | Targeting the Notch signaling pathway | ||